Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176566 · ClinicalTrials.gov registry record · Phase 2
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
A Phase 2 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00176566 is a Phase 2 study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 8 participants.
The verdict
NCT00176566, a Phase 2 study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
You have been asked to participate in this research study because you have or may have oral leukoplakia. Oral leukoplakia is described as a white patch or plaque on the oral mucosa (mouth) that will not rub off and cannot be removed by scraping, reversed by elimination of obvious irritants (things that cause redness and/or swelling) such as dentures (artificial replacment for missing teeth), or lesions as described that are diagnosed by your dentist.
Interventions
- DRUG Lozenge Intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176566
The ClinicalTrials.gov registry entry for NCT00176566 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lozenge Intake is the first listed.
NCT00176566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00176566 about?
NCT00176566 is a clinical study titled "A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia". You have been asked to participate in this research study because you have or may have oral leukoplakia. Oral leukoplakia is described as a white patch or plaque on the oral mucosa (mouth) that will not rub off and cannot be removed by scraping, reversed by elimination of obvious irritants (things t...
What is the current status of trial NCT00176566?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2003-09. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00176566?
The interventions under investigation include: Lozenge Intake (DRUG).
Who is sponsoring clinical trial NCT00176566?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.